News

At the same time, the company has secured a $2 million investment from a private investor to support the MDR-TB (multiple drug-resistant tuberculosis) drug development and clinical trial

In the trial, 27 patients who had previously failed standard therapies were divided into six dose groups receiving IV infusions of HuMax-EGFr at doses of 0.15, 0.5, 1,

The FDA approved Mycamine (micafungin sodium) in March 2005 for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation and the treatment of esophageal candidiasis.

Results from two published clinical trials suggest that symptoms produced by non-steroidal anti-inflammatory drugs (NSAIDs), such as moderate to severe pain, burning and discomfort in the upper abdomen,

Cephalon is required to pay an additional $40 million of cash payments upon the achievement of certain regulatory milestones. At the close of the transaction, Salmedix is expected

PXD101 is a histone deacetylase (HDAC) inhibitor being co-developed by CuraGen and TopoTarget for the treatment of solid and hematologic cancers. It is currently in a phase II

A total of 829 older adults (aged 64-93 years) were enrolled in a randomized, double-blind, five-week study. Study participants completed next-morning sleep questionnaires regarding their previous night’s sleep

The collaboration, Access’ third oral drug delivery research collaboration, is aimed at combining Access’ proprietary vitamin B12 oral drug delivery technology with Hunter-Fleming’s Alzheimer’s disease drug candidate, Oligotropin

This study is part of a series of single agent and combination studies of the vascular endothelial growth factor (VEGF) trap in a variety of cancer types. Regeneron